Literature DB >> 22983418

Prognostic factors and survival patterns in pediatric low-grade gliomas over 4 decades.

Ryan S Youland1, Shariq S Khwaja, David A Schomas, Gesina F Keating, Nicholas M Wetjen, Nadia N Laack.   

Abstract

BACKGROUND: This study reports changes in long-term survival after the introduction of modern imaging in pediatric patients with low-grade gliomas (LGGs).
METHODS: Records from 351 consecutive pediatric patients diagnosed with LGG between 1970 and 2009 at Mayo Clinic Rochester were reviewed and divided into diagnosis before (group I: 1970 to 1989) and after (group II: 1990 to 2009) postoperative magnetic resonance imaging became regularly used in pediatric LGG.
RESULTS: Median progression-free survival (PFS) and overall survival (OS) were not reached. Overall, 10-year PFS was 62% and OS was 90%. On multivariate analysis, improved PFS was associated with gross total resection (GTR; P<0.0001) and postoperative radiation therapy (RT; P<0.0001). In those undergoing less than GTR, PFS was improved with RT, nearing rates of patients receiving GTR (P=0.12). On multivariate analysis, higher OS was associated with GTR (P<0.0001) and pilocytic histology (P=0.03). Group II had fewer headaches, fewer sensory/motor symptoms, less postoperative RT, and more GTRs. OS and PFS were not different between the groups.
CONCLUSIONS: This large series of pediatric LGG patients with long-term follow-up found no significant changes in OS or PFS over time. Overall, GTR was associated with improved OS and PFS. RT was associated with an improvement in PFS, with the greatest benefit seen in patients undergoing less than GTR.

Entities:  

Mesh:

Year:  2013        PMID: 22983418     DOI: 10.1097/MPH.0b013e3182678bf8

Source DB:  PubMed          Journal:  J Pediatr Hematol Oncol        ISSN: 1077-4114            Impact factor:   1.289


  9 in total

Review 1.  Paediatric gliomas: diagnosis, molecular biology and management.

Authors:  Alexandros Blionas; Dimitrios Giakoumettis; Alexia Klonou; Eleftherios Neromyliotis; Ploutarchos Karydakis; Marios S Themistocleous
Journal:  Ann Transl Med       Date:  2018-06

Review 2.  Advances in the management of low-grade gliomas.

Authors:  Amulya A Nageswara Rao; Roger J Packer
Journal:  Curr Oncol Rep       Date:  2014       Impact factor: 5.075

Review 3.  The use and efficacy of chemotherapy and radiotherapy in children and adults with pilocytic astrocytoma.

Authors:  Matthew W Parsons; Nicholas S Whipple; Matthew M Poppe; Joe S Mendez; Donald M Cannon; Lindsay M Burt
Journal:  J Neurooncol       Date:  2020-10-31       Impact factor: 4.130

4.  Patterns of care and treatment outcomes in older adults with low grade glioma: a 50-year experience.

Authors:  Ryan S Youland; David A Schomas; Paul D Brown; Ian F Parney; Nadia N I Laack
Journal:  J Neurooncol       Date:  2017-04-21       Impact factor: 4.130

Review 5.  Conventional chemotherapy and perspectives for molecular-based oncological treatment in pediatric hemispheric low-grade gliomas.

Authors:  María Baro Fernández; Vanesa Pérez Alonso
Journal:  Childs Nerv Syst       Date:  2016-09-20       Impact factor: 1.475

6.  Awake Craniotomy with Noninvasive Brain Mapping by 3-Tesla Functional Magnetic Resonance Imaging for Excision of Low-grade Glioma: A Case of a Young Patient from Pakistan.

Authors:  Atta Ul Aleem Bhatti; Nasir Khan Jakhrani; Maria Adnan Parekh
Journal:  Asian J Neurosurg       Date:  2018 Apr-Jun

7.  Methylation profiling of paediatric pilocytic astrocytoma reveals variants specifically associated with tumour location and predictive of recurrence.

Authors:  Alexandra Sexton-Oates; Andrew Dodgshun; Volker Hovestadt; David T W Jones; David M Ashley; Michael Sullivan; Duncan MacGregor; Richard Saffery
Journal:  Mol Oncol       Date:  2018-07-06       Impact factor: 6.603

8.  Natural History of Pediatric Low-Grade Glioma Disease - First Multi-State Model Analysis.

Authors:  Anna-Maria Goebel; Astrid K Gnekow; Daniela Kandels; Olaf Witt; Rene Schmidt; Pablo Hernáiz Driever
Journal:  J Cancer       Date:  2019-10-17       Impact factor: 4.207

Review 9.  Pre-Adult MRI of Brain Cancer and Neurological Injury: Multivariate Analyses.

Authors:  Jacob Levman; Emi Takahashi
Journal:  Front Pediatr       Date:  2016-06-23       Impact factor: 3.418

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.